Boiron (BOIRF) Stock Price, News & Analysis

Company Overview

Boiron is a France-based healthcare company specializing in the development, manufacture and distribution of homeopathic medicines and other self-care products. Its portfolio includes products intended for common health needs such as cold and flu symptoms, sleep, stress, digestive concerns and minor pain.

The company’s best-known brands include Oscillococcinum, commonly marketed for flu-like symptoms, and other products sold under the Boiron name in pharmacies and retail healthcare channels. In addition to homeopathic medicines, Boiron offers selected over-the-counter healthcare products, dietary supplements and related wellness products, depending on the market.

Founded in 1932 by twin brothers Jean and Henri Boiron, the company is headquartered in Messimy, France. Boiron serves customers through operations and distribution networks in France and other European countries, North America and additional international markets. Its products are generally distributed through pharmacies, healthcare retailers and e-commerce channels.

Key Stats

• Today's Range: $31.50 to $31.50
• 50-Day Range: $31.50 to $31.50
• 52-Week Range: $31.50 to $31.90
• Volume: 2 shs
• Average Volume: 333 shs
• Market Capitalization: N/A
• P/E Ratio: 7.99
• Dividend Yield: 3.81%
• Price Target: N/A
• Consensus Rating: N/A

Boiron Stock Analysis - MarketRank™

Boiron scored higher than 13% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Boiron.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Boiron is 7.99, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.41.

Price to Earnings Ratio vs. Sector

The P/E ratio of Boiron is 7.99, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.56.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Boiron has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Boiron has recently increased by 100.00%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Boiron pays a meaningful dividend of 2.01%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Boiron does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Boiron is 30.44%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

News Sentiment

Boiron has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.58 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Boiron this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.1 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Boiron insiders have not sold or bought any company stock.

Percentage Held by Institutions

9.72% of the stock of Boiron is held by institutions.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:BOIRF
• CIK: N/A
• Web: www.boiron.com
• Phone: 33 4 78 45 61 00
• Fax: N/A
• Employees: 2,634
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 7.99
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A